Main > NEUROLOGY. > Multiple Sclerosis > Treatment > Paclitaxel. > Patent. > Claims > Claim 1: Multiple Sclerosis Treat. > Method. Adm. to Patient Paclitaxel. > Claim 2: Systemic Adm. Claim 3: > Oral or IntraVenous Adm. Claim 4:

---

Oral or IntraVenous Adm. Claim 4:'s subsections
Dosage: 10-75 mg/m.sup.2 Once

Oral or IntraVenous Adm. Claim 4:'s products
This section has no products